Psoriasis: early response to MTX portends 4-mo outcome

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • 4-wk response to methotrexate (MTX) treatment is predictive of 16-wk response in patients with moderate-to-severe psoriasis.

Why this matters

  • Early response prediction may limit safety risk.

Key results

  • Achievement of 25% reduction from baseline Psoriasis Area and S...